Loading...

Leo Mascarenhas, MD

Title(s)Associate Professor of Clinical Pediatrics
AddressCHL 4650 W Sunset Boulevard
Off Campus
Los Angeles CA 90027
Phone+1 323 361 2529
vCardDownload vCard
    Other Positions
    Title(s)Section Head, Oncology

    Title(s)Director Solid Tumor Program

    Title(s)Director of Clinical Trials Office


    Collapse Overview 
    Collapse Overview
    Leo Mascarenhas, MD is director of the Clinical Trials Office in the Children’s Center for Cancer and Blood Diseases and Principal Investigator for the National Cancer Institute funded Children’s Oncology Group grant at Children’s Hospital Los Angeles. He is an associate professor of Clinical Pediatrics at the Keck School of Medicine of the University of Southern California.

    Childhood cancer is the leading cause of disease-related death in pediatrics in the United States. Dr. Mascarenhas and his team's research focuses on developmental therapeutics for patients with bone and soft tissue sarcomas. Despite the remarkable progress made in the treatment of childhood cancer in the last four decades, improved therapies are still needed for our patients with a poor prognosis and less toxic therapies for those destined to survive. This can be accomplished only through basic, translational and clinical research.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors. Neuro Oncol. 2020 Jun 09; 22(6):785-796. Panwalkar P, Pratt D, Chung C, Dang D, Le P, Martinez D, Bayliss JM, Smith KS, Adam M, Potter S, Northcott PA, Mascarenhas L, Shows J, Pawel B, Margol A, Huang A, Judkins AR, Venneti S. PMID: 31912158.
      View in: PubMed   Mentions: 1     Fields:    
    2. Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung. Sarcoma. 2020; 2020:7935475. Baird K, Glod J, Steinberg SM, Reinke D, Pressey JG, Mascarenhas L, Federman N, Marina N, Chawla S, Lagmay JP, Goldberg J, Milhem M, Loeb DM, Butrynski JE, Turpin B, Staddon A, Spunt SL, Jones RL, Rodler ET, Schuetze SM, Okuno SH, Helman L. PMID: 32398945.
      View in: PubMed   Mentions:
    3. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. Lancet Oncol. 2020 Apr; 21(4):531-540. Hong DS, DuBois SG, Kummar S, Farago AF, Albert CM, Rohrberg KS, van Tilburg CM, Nagasubramanian R, Berlin JD, Federman N, Mascarenhas L, Geoerger B, Dowlati A, Pappo AS, Bielack S, Doz F, McDermott R, Patel JD, Schilder RJ, Tahara M, Pfister SM, Witt O, Ladanyi M, Rudzinski ER, Nanda S, Childs BH, Laetsch TW, Hyman DM, Drilon A. PMID: 32105622.
      View in: PubMed   Mentions:    Fields:    
    4. Expanding the spectrum of dicer1-associated sarcomas. Mod Pathol. 2020 01; 33(1):164-174. Warren M, Hiemenz MC, Schmidt R, Shows J, Cotter J, Toll S, Parham DM, Biegel JA, Mascarenhas L, Shah R. PMID: 31537896.
      View in: PubMed   Mentions:    Fields:    
    5. Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2019 11 01; 37(31):2866-2874. Mascarenhas L, Chi YY, Hingorani P, Anderson JR, Lyden ER, Rodeberg DA, Indelicato DJ, Kao SC, Dasgupta R, Spunt SL, Meyer WH, Hawkins DS. PMID: 31513481.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2019 08 01; 125(15):2602-2609. Mascarenhas L, Lyden ER, Breitfeld PP, Walterhouse DO, Donaldson SS, Rodeberg DA, Parham DM, Anderson JR, Meyer WH, Hawkins DS. PMID: 31067356.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. J Clin Oncol. 2019 06 01; 37(16):1424-1431. Davis LE, Bolejack V, Ryan CW, Ganjoo KN, Loggers ET, Chawla S, Agulnik M, Livingston MB, Reed D, Keedy V, Rushing D, Okuno S, Reinke DK, Riedel RF, Attia S, Mascarenhas L, Maki RG. PMID: 31013172.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    8. Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial. Cancer Chemother Pharmacol. 2019 07; 84(1):41-50. Verschuur AC, Bajciová V, Mascarenhas L, Khosravan R, Lin X, Ingrosso A, Janeway KA. PMID: 31006038.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    9. Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2019 Apr; 120(8):869. Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30880335.
      View in: PubMed   Mentions:    Fields:    
    10. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50. Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N. PMID: 30685685.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    11. The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. Cancer. 2018 11 01; 124(21):4241-4247. DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, Cruickshank S, Cox MC, Hawkins DS, Mascarenhas L, Pappo AS. PMID: 30204247.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    12. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2018 08; 119(5):615-621. Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30131550.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2018 09 20; 36(27):2770-2777. Hawkins DS, Chi YY, Anderson JR, Tian J, Arndt CAS, Bomgaars L, Donaldson SS, Hayes-Jordan A, Mascarenhas L, McCarville MB, McCune JS, McCowage G, Million L, Morris CD, Parham DM, Rodeberg DA, Rudzinski ER, Shnorhavorian M, Spunt SL, Skapek SX, Teot LA, Wolden S, Yock TI, Meyer WH. PMID: 30091945.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    14. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol. 2018 05; 19(5):705-714. Laetsch TW, DuBois SG, Mascarenhas L, Turpin B, Federman N, Albert CM, Nagasubramanian R, Davis JL, Rudzinski E, Feraco AM, Tuch BB, Ebata KT, Reynolds M, Smith S, Cruickshank S, Cox MC, Pappo AS, Hawkins DS. PMID: 29606586.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    15. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018 02 22; 378(8):731-739. Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM. PMID: 29466156.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    16. Three synchronous malignancies in a patient with DICER1 syndrome. Eur J Cancer. 2018 04; 93:140-143. Moke DJ, Thomas SM, Hiemenz MC, Nael A, Wang K, Shillingford N, Biegel JA, Mascarenhas L. PMID: 29395683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study. J Clin Oncol. 2017 Nov 10; 35(32):3688-3696. Wang X, Sun CL, Hageman L, Smith K, Singh P, Desai S, Hawkins DS, Hudson MM, Mascarenhas L, Neglia JP, Oeffinger KC, Ritchey AK, Robison LL, Villaluna D, Landier W, Bhatia S. PMID: 28976792.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution. Histopathology. 2017 Nov; 71(5):813-822. Zhou S, Venkatramani R, Gupta S, Wang K, Stein JE, Wang L, Mascarenhas L. PMID: 28660626.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. De novo hepatocellular carcinoma post-multivisceral transplantation in a child. Pediatr Transplant. 2017 11; 21(7). Tran P, Zhou S, Wang L, Finegold M, Mascarenhas L, Alexopolous S, Genyk Y, Kerkar N. PMID: 29024228.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65(1). Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. PMID: 28748602.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    21. Bronchial Mucoepidermoid Carcinoma With the Classic MAML2 Gene Rearrangement in a 2-year-old Boy. Pediatr Dev Pathol. 2018 Sep-Oct; 21(5):480-485. Szymanski LJ, Molas-Torreblanca K, Bawab R, Kim E, Don D, Mascarenhas L, Stanley P, Zhou S, Shillingford N. PMID: 28492094.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Inherited germline ATRX mutation in two brothers with ATR-X syndrome and osteosarcoma. Am J Med Genet A. 2017 May; 173(5):1390-1395. Ji J, Quindipan C, Parham D, Shen L, Ruble D, Bootwalla M, Maglinte DT, Gai X, Saitta SC, Biegel JA, Mascarenhas L. PMID: 28371217.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    23. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1. J Clin Oncol. 2017 May 20; 35(15):1730-1736. Landier W, Hageman L, Chen Y, Kornegay N, Evans WE, Bostrom BC, Casillas J, Dickens DS, Angiolillo AL, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S. PMID: 28339328.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    24. Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study. Blood. 2017 04 06; 129(14):1919-1926. Landier W, Chen Y, Hageman L, Kim H, Bostrom BC, Casillas JN, Dickens DS, Evans WE, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Relling MV, Wong FL, Bhatia S. PMID: 28153823.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    25. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS. PMID: 27569442.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    26. Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies. Cancer Med. 2016 Feb; 5(2):294-303. Reed DR, Mascarenhas L, Manning K, Hale GA, Goldberg J, Gill J, Sandler E, Isakoff MS, Smith T, Caracciolo J, Lush RM, Juan TH, Lee JK, Neuger AM, Sullivan DM. PMID: 26714427.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    27. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Mar; 63(3):493-8. Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N. PMID: 26579879.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Pilot Feasibility Study of Comprehensive Pulmonary Evaluation Following Lung Radiation Therapy. J Pediatr Hematol Oncol. 2015 Oct; 37(7):e412-8. De A, Mascarenhas L, Kamath S, LaRiviere A, Goodarzian F, Keens TG, Venkatramani R. PMID: 26241727.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    29. Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e399-401. Chien MC, Mascarenhas L, Hammoudeh JA, Venkatramani R. PMID: 26056788.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e356-60. Venkatramani R, Triche TJ, Wang L, Shimada H, Mascarenhas L. PMID: 26056800.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JAMA Oncol. 2015 Jun; 1(3):287-95. Bhatia S, Landier W, Hageman L, Chen Y, Kim H, Sun CL, Kornegay N, Evans WE, Angiolillo AL, Bostrom B, Casillas J, Lew G, Maloney KW, Mascarenhas L, Ritchey AK, Termuhlen AM, Carroll WL, Wong FL, Relling MV. PMID: 26181173.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    32. Hepatoblastoma in a patient with methylmalonic aciduria. Am J Med Genet A. 2015 Mar; 167A(3):635-8. Chan R, Mascarenhas L, Boles RG, Kerkar N, Genyk Y, Venkatramani R. PMID: 25691417.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Sarcomas. Pediatr Clin North Am. 2015 Feb; 62(1):179-200. HaDuong JH, Martin AA, Skapek SX, Mascarenhas L. PMID: 25435119.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    34. Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable? Hum Pathol. 2015 Apr; 46(4):620-4. Zhou S, Gomulia E, Mascarenhas L, Wang L. PMID: 25649007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma. Pediatr Hematol Oncol. 2015 Feb; 32(1):26-31. Tran HC, Marachelian A, Venkatramani R, Jubran RF, Mascarenhas L. PMID: 25551355.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    36. De novo congenital melanoma: analysis of 2 cases with array comparative genomic hybridization. Am J Dermatopathol. 2014 Nov; 36(11):915-9. Su A, Low L, Li X, Zhou S, Mascarenhas L, Barnhill RL. PMID: 25051103.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    37. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015 Jan; 102(1):108-13. Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L. PMID: 25349947.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and doxorubicin. J Pediatr Hematol Oncol. 2014 Jul; 36(5):e307-9. Venkatramani R, Mascarenhas L. PMID: 24276035.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors. Clin Cancer Res. 2014 Dec 15; 20(24):6314-23. Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S. PMID: 24947931.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    40. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatr Blood Cancer. 2014 Sep; 61(9):1679-84. De A, Guryev I, LaRiviere A, Kato R, Wee CP, Mascarenhas L, Keens TG, Venkatramani R. PMID: 24789770.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer. 2014 Aug; 61(8):1357-61. Venkatramani R, Shoureshi P, Malvar J, Zhou S, Mascarenhas L. PMID: 24789740.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    42. Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):1109-14. Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S. PMID: 24718281.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation. Pediatr Pulmonol. 2015 Jun; 50(6):596-603. De A, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Mascarenhas L, Keens TG, Venkatramani R. PMID: 24644268.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. Pediatr Blood Cancer. 2014 Jul; 61(7):1277-81. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. PMID: 24482138.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    45. Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma. J Clin Oncol. 2014 May 20; 32(15):e57-60. Puliyel MM, Mascarenhas L, Zhou S, Sapra A, Dal Cin P, French CA, Venkatramani R. PMID: 24470009.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Hepatoblastoma and hypoplastic kidneys: a new association. Pediatr Blood Cancer. 2014 Aug; 61(8):1476-8. Chan R, Mascarenhas L, Venkatramani R. PMID: 24623570.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Hepatoblastoma in a 15-month-old female with trisomy 13. Am J Med Genet A. 2014 Feb; 164A(2):472-5. Shah R, Tran HC, Randolph L, Mascarenhas L, Venkatramani R. PMID: 24311532.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    48. Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab. Pediatr Blood Cancer. 2014 Apr; 61(4):756-9. Venkatramani R, Malogolowkin MH, Mascarenhas L. PMID: 24115645.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Inflammatory myofibroblastic tumors in childhood. Pediatr Hematol Oncol. 2013 Oct; 30(7):640-5. Mehta B, Mascarenhas L, Zhou S, Wang L, Venkatramani R. PMID: 23988029.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416. Venkatramani R, Malogolowkin M, Davidson TB, May W, Sposto R, Mascarenhas L. PMID: 23894304.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    51. Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):942-8. Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L. PMID: 23726005.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Ewing sarcoma of the tibia mimicking fibrous dysplasia. J Pediatr Orthop B. 2013 May; 22(3):222-7. Arkader A, Myung KS, Stanley P, Mascarenhas L. PMID: 22094991.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Orthopaedic case of the month: A 14-year-old boy with a medial thigh soft tissue mass. Clin Orthop Relat Res. 2013 May; 471(5):1433-8. Ibrahim DA, Mascarenhas L, Tovar JP, Arkader A. PMID: 23129475.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors. Pediatr Blood Cancer. 2013 Jul; 60(7):1103-7. Mascarenhas L, Malogolowkin M, Armenian SH, Sposto R, Venkatramani R. PMID: 23335436.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    55. Pleuropulmonary blastoma: a single-institution experience. J Pediatr Hematol Oncol. 2012 Jul; 34(5):e182-5. Venkatramani R, Malogolowkin MH, Wang L, Mascarenhas L. PMID: 22584785.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group. J Clin Oncol. 2012 Jun 10; 30(17):2094-101. Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM, Mascarenhas L, Ritchey AK, Casillas JN, Dickens DS, Meza J, Carroll WL, Relling MV, Wong FL. PMID: 22564992.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    57. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma. Pediatr Blood Cancer. 2012 Sep; 59(3):493-8. Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L. PMID: 22190448.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Correlation of long-term pulmonary injury with radiation dose distribution in childhood cancer survivors. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):237-240. Venkatramani R, Olch AJ, Mascarenhas L, Yoon S, Suterwala B, Mehta B, Wong K. PMID: 24674127.
      View in: PubMed   Mentions:    Fields:    
    59. Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Dec 01; 57(6):939-42. Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, Marina N, Conrad EU, Hawkins DS. PMID: 21480474.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    60. Expanded Access Through Cancer Trials Support Unit to Children's Oncology Group Sarcoma Trial AEWS1031 for Adolescents and Young Adults. J Adolesc Young Adult Oncol. 2011 Mar; 1(1):61-3. Mascarenhas L, Bond MC, Seibel NL. PMID: 26812570.
      View in: PubMed   Mentions: 1     Fields:    
    61. Gorham's disease and diffuse lymphangiomatosis in children and adolescents. Pediatr Blood Cancer. 2011 Apr; 56(4):667-70. Venkatramani R, Ma NS, Pitukcheewanont P, Malogolowkin MH, Mascarenhas L. PMID: 21298758.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    62. Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2010 Oct 20; 28(30):4658-63. Mascarenhas L, Lyden ER, Breitfeld PP, Walterhouse DO, Donaldson SS, Paidas CN, Parham DM, Anderson JR, Meyer WH, Hawkins DS. PMID: 20837952.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    63. Recurrent and refractory giant cell tumor of the jaw. J Craniofac Surg. 2009 Nov; 20(6):2245-8. Rovelo MO, Kim R, Mascarenhas L, Hammoudeh J, Urata MM. PMID: 19934683.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma. J Bone Joint Surg Am. 2009 Mar 01; 91(3):604-12. Imran H, Enders F, Krailo M, Sim F, Okuno S, Hawkins D, Neglia J, Randall RL, Womer R, Mascarenhas L, Arndt CA. PMID: 19255220.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Sep; 51(3):334-8. Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. PMID: 18506764.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    66. Invasive diagnostic procedures for pulmonary infiltrates in pediatric hematopoietic stem cell transplant recipients. Pediatr Transplant. 2007 Nov; 11(7):736-42. Armenian SH, Hoffman JA, Butturini AM, Kapoor N, Mascarenhas L. PMID: 17910650.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. Cancer. 2007 Nov 01; 110(9):2061-6. Madigan CE, Armenian SH, Malogolowkin MH, Mascarenhas L. PMID: 17828773.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    68. Treatment of infantile choriocarcinoma of the liver. Pediatr Blood Cancer. 2007 Jul; 49(1):99-102. Yoon JM, Burns RC, Malogolowkin MH, Mascarenhas L. PMID: 16206190.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    69. Severe methotrexate toxicity precipitated by intravenous radiographic contrast. J Pediatr Hematol Oncol. 2007 Jul; 29(7):496-9. Harned TM, Mascarenhas L. PMID: 17609630.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. Evaluation of persistent pulmonary infiltrates in pediatric oncology patients. Pediatr Blood Cancer. 2007 Feb; 48(2):165-72. Armenian SH, La Via WV, Siegel SE, Mascarenhas L. PMID: 16411212.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. Transient myeloproliferative disorder in a phenotypically normal infant with i(21q) mosaicism. Cancer Genet Cytogenet. 2002 Jul 15; 136(2):138-40. Wu SQ, Loh KT, Chen XR, Joo WJ, Mascarenhas L. PMID: 12237238.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    72. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. Blood. 2000 Aug 15; 96(4):1317-26. Stripecke R, Cardoso AA, Pepper KA, Skelton DC, Yu XJ, Mascarenhas L, Weinberg KI, Nadler LM, Kohn DB. PMID: 10942373.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    73. Gene delivery to human B-precursor acute lymphoblastic leukemia cells. Blood. 1998 Nov 15; 92(10):3537-45. Mascarenhas L, Stripecke R, Case SS, Xu D, Weinberg KI, Kohn DB. PMID: 9808545.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells